MABC605MI

MilliporeSigma™ TXNIP, Mouse, Unlabeled, Clone: 3A7.1,

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 MABC605MI-Each-of-1 In Stock ₹ 42,968.31

MABC605MI - Each of 1

₹ 42,968.31

In Stock

Quantity

1

Base Price: ₹ 42,968.31

GST (18%): ₹ 7,734.296

Total Price: ₹ 50,702.606

Antigen

TXNIP

Classification

Monoclonal

Concentration

Please refer to lot specific datasheet.

Formulation

Purified mouse monoclonal IgG2bκ antibody in buffer containing 0.1M Tris-Glycine (pH 7.4), 150mM NaCl with 0.05% Sodium Azide.

Gene Accession No.

Q9H3M7

Immunogen

GST-tagged recombinant fragment from the N-terminal half of human TXNIP.

Quantity

100 μg

Research Discipline

Apoptosis & Cancer

Gene ID (Entrez)

NP_006463

Target Species

Human

Form

Purified

Applications

Western Blot

Clone

3A7.1

Conjugate

Unconjugated

Gene

TXNIP, VDUP1

Host Species

Mouse

Purification Method

Protein G Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Test Specificity

Clone 3A7.1 targets an epitope within the N-terminal half of TXNIP. Cross-reactivity to human and mouse spliced isoform 2 is likely, but has not been confirmed.

Content And Storage

Stable for 1 year at 2°-8°C from date of receipt.

Isotype

IgG2b κ

Related Products

Img

MilliporeSigma™

MABC1040MI

--

Img

MilliporeSigma™

MABC1037MI

--

Img

MilliporeSigma™

MABC1211MI

--

Img

MilliporeSigma™

MABS1166MI

--

Img

MilliporeSigma™

MABE949MI

--

Img

MilliporeSigma™

MABS1161MI

--

Img

MilliporeSigma™

MABF1070MI

--

Img

MilliporeSigma™

MABS1713MI

--

Description

  • Thioredoxin-interacting protein (UniProt Q9H3M7; also known as Thioredoxin-binding protein 2, Vitamin D3 up-regulated protein 1) is encoded by the TXNIP (also known as VDUP1) gene (Gene ID 10628) in human
  • Thioredoxin interacting protein (TXNIP) binds thioredoxin active cysteine residue and suppresses its antioxidant activity
  • TXNIP overexpression results in increased cellular ROS level and oxidative cell death, while TXNIP suppression enhances cellular resistance to oxidative injury
  • TXNIP is also shown to inhibit cellular glucose uptake by downregulating glucose transporter 1 (GLUT1) plasma membrane localization, and TXNIP expression is found to be markedly suppressed in many cancers, making TXNIP a potential anticancer therapeutic target.